We are pleased to announce renowned keynote speakers (as of February 2021):
Application of microphysiological systems to drug safety assessment: progress and challenges
Rhiannon David, AstraZeneca, Cambridge/UK
Advancing regulatory science through innovation; in vitro microphysiological systems
Suzanne C. Fitzpatrick, CFSAN/FDA, College Park Maryland, MD/USA
Toward a world of ElectroGenetics
Martin Fussenegger, ETH Zurich/CH
Organotypic 3D models to characterize the molecular requirements of immune cell infiltration and activation
Wolfgang Sommergruber, University of Applied Sciences, Vienna/A
